Skip to main content
STRATEC SE logo

STRATEC SE — Investor Relations & Filings

Ticker · SBS ISIN · DE000STRA555 LEI · 529900ZZJWANAFSPGV30 F Manufacturing
Open in API
Filings indexed 828 across all filing types
Latest filing 2011-08-15 Director's Dealing
Country DE Germany
Listing F SBS

About STRATEC SE

https://www.stratec.com/home

STRATEC SE is a global partner specializing in the design and manufacturing of fully automated solutions for OEM partners in the clinical diagnostics and life sciences industries. The company provides a comprehensive, integrated portfolio covering the entire value chain, from development and design to production and quality assurance. Its core offerings include fully automated analyzer systems (instrumentation), custom software and digital IoT solutions, and smart polymer-based consumables. Leveraging decades of experience and a broad technology base, STRATEC delivers tailored, high-quality systems that meet stringent regulatory standards, enabling its partners to bring advanced diagnostic and life science products to market.

Recent filings

Filing Released Lang Actions
DGAP-DD: STRATEC Biomedical AG english
Director's Dealing Classification · 1% confidence The document is explicitly titled 'Directors’ Dealings' and contains a 'Notification concerning transactions by persons performing managerial responsibilities pursuant to section 15a of the WpHG Directors’ Dealings notification'. It details a sale transaction by a 'Member of a managing body' (Marcus Wolfinger) involving the company's ordinary shares, including dates, prices, and quantities. This directly matches the definition for Director's Dealing.
2011-08-15 English
STRATEC - Growth trajectory confirmed after first six months of 2011
Earnings Release Classification · 1% confidence The document text explicitly states it is announcing figures for the period January 1, 2011, to June 30, 2011, upon the publication of its 'interim report as of June 30, 2011'. It provides key financial metrics (Sales, EBIT, Net Income) for the first six months (Q1-Q2) of the year. This content structure—a summary announcement of half-year financial results—aligns perfectly with the definition of an Interim/Quarterly Report (IR). Although it mentions the full 'Interim Report' is available elsewhere, the document itself contains the core results summary, making it an Earnings Release (ER) or Interim Report (IR). Given the comprehensive nature of the six-month figures and the explicit mention of the 'interim report', IR is the most appropriate classification over the more general ER (which usually focuses on quarterly highlights). It is not a full Annual Report (10-K) as it covers only six months. H1 2011
2011-07-27 English
Q2 Report 2011
Interim / Quarterly Report Classification · 1% confidence The document is titled 'Interim Report as of June 30, 2011' and contains comprehensive financial statements, including a consolidated balance sheet, statement of comprehensive income, cash flow statement, and notes to the interim report. It provides detailed financial performance data for the first half of the year, which fits the definition of an Interim/Quarterly Report (IR). H2 2011
2011-07-27 German
Report Publication Announcement 2011
Report Publication Announcement Classification · 1% confidence The document is very short (1530 characters) and explicitly states that a financial report ('Financial report of the group (half-year)') will be disclosed on a future date (July 27, 2011), providing links where the report will be available. This structure—announcing the future publication of a report rather than containing the report itself—fits the definition of a Report Publication Announcement (RPA). The document is not the comprehensive Interim/Quarterly Report (IR) itself, but the notice about its release.
2011-07-20 English
STRATEC Biomedical AG: Release according to Article 26a of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is very short (1297 characters) and explicitly announces the 'Total Voting Rights' as of May 31, 2011, referencing Article 26a of the WpHG (German Securities Trading Act). This type of announcement, which reports the total number of shares carrying voting rights, directly corresponds to the definition of 'Declaration of Voting Results & Voting Rights Announcements' (DVA). It is not a full report, a management change, or a dividend notice.
2011-05-31 English
STRATEC tightens 2011 revenue forecast
Earnings Release Classification · 1% confidence The document is a short corporate news release dated May 9, 2011, announcing an update to the company's revenue forecast for 2011 ("STRATEC tightens 2011 revenue forecast"). It provides specific financial figures (EUR 114 million to EUR 123 million) and maintains the EBIT margin guidance. This is a typical structure for an Earnings Release (ER) which provides key financial highlights shortly after a period or when significant guidance changes occur. It is too brief and focused on immediate results/guidance to be a full Annual Report (10-K) or Interim Report (IR). Since it is an announcement of financial results/guidance changes, ER is the most appropriate classification. FY 2011
2011-05-09 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.